An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome
Journal article
Ng E. et al, (2023), Journal of General Virology, 104
Defining the key intrahepatic gene networks in HCV infection driven by sex
Journal article
Marchi E. et al, (2023), Gut, 72, 984 - 994
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Journal article
Murray SM. et al, (2023), Nature Reviews Immunology, 23, 304 - 316
Genetic variation inTERTmodifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study
Journal article
Buch S. et al, (2023), Gut, 72, 381 - 391
A systematic review of Hepatitis B virus (HBV) prevalence and genotypes in Kenya: Data to inform clinical care and health policy
Journal article
Downs LO. et al, (2023), PLOS Global Public Health, 3, e0001165 - e0001165
Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus
Journal article
Sy A. et al, (2023), PLOS ONE, 18, e0280551 - e0280551
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study
Journal article
Flower B. et al, (2023), eLife, 12
A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117
Journal article
Zacharopoulou P. et al, (2022), Current Opinion in HIV and AIDS, 17, 352 - 358
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Journal article
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis
Journal article
Innes H. et al, (2022), Hepatology Communications, 6, 1213 - 1226
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Journal article
Tomic A. et al, (2022), Nature Communications, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
Comprehensive Comparative Analysis of Standard Validated, Genetic, and Novel Biomarkers to Enhance Prognostic Risk-Stratification in Patients With Hepatitis C Virus Cirrhosis
Journal article
Innes H. et al, (2022), Clinical and Translational Gastroenterology, 13, e00462 - e00462
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study
Journal article
Angyal A. et al, (2022), The Lancet Microbe, 3, e21 - e31
Using host genetics to infer the global spread and evolutionary history of HCV subtype 3a
Journal article
Lin S-K. et al, (2021), Virus Evolution, 7
Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus
Journal article
Lin G-L. et al, (2021), Nature Communications, 12
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infection
Journal article
Innes H. et al, (2021), JHEP Reports, 3, 100384 - 100384
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses
Journal article
Ogbe A. et al, (2021), Nature Communications, 12
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adults
Journal article
Vieira VA. et al, (2021), PLOS Pathogens, 17, e1010090 - e1010090